RXi Pharmaceuticals Corporation (RXII) Dropped -5.56% or -0.15 To Price $2.55 On Monday


RXi Pharmaceuticals Corporation (RXII) dropped -5.56% or -0.15 to $2.55. It is around 76087 shares traded, which is 78.47% compare to the average total volume 96959. The market cap of RXII is $604281. The year to date change is -50.91%. The 52 week price range is from $2.55 to $11.2. Price of RXII have changed -16.67% during last week. It have changed -25.00% over last month, -54.25% over last 3 months, -51.79% over last 6 months and -60.87% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 4.14. It is 62.35% above current price. The 200-day Moving Averages for RXII is 5.38. It is 110.98% above current price. The 52-week High is 11.2. It is 339.22% from the current price. The 52-week Low is 2.55. The stock hits 52-week low today.

There are some statistics of RXII. It is has market cap $604281. The share outstanding is 236973. The average volume is 96959. The percent of top 15 Institution holding is 0.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -459.76%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -271.89%.


Tags:

Share this post